GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enanta Pharmaceuticals Inc (FRA:9EP) » Definitions » Common Stock

Enanta Pharmaceuticals (FRA:9EP) Common Stock : €0.19 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Enanta Pharmaceuticals Common Stock?

Enanta Pharmaceuticals's quarterly common stock increased from Mar. 2024 (€0.20 Mil) to Jun. 2024 (€0.20 Mil) but then declined from Jun. 2024 (€0.20 Mil) to Sep. 2024 (€0.19 Mil).

Enanta Pharmaceuticals's annual common stock declined from Sep. 2022 (€0.21 Mil) to Sep. 2023 (€0.20 Mil) and declined from Sep. 2023 (€0.20 Mil) to Sep. 2024 (€0.19 Mil).


Enanta Pharmaceuticals Common Stock Historical Data

The historical data trend for Enanta Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enanta Pharmaceuticals Common Stock Chart

Enanta Pharmaceuticals Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.17 0.21 0.20 0.19

Enanta Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.19 0.20 0.20 0.19

Enanta Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Enanta Pharmaceuticals Business Description

Traded in Other Exchanges
Address
4 Kingsbury Avenue, Watertown, MA, USA, 02472
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Enanta Pharmaceuticals Headlines

No Headlines